Total Payments
$1,387
2023 Payments
$220.18
Companies
13
Transactions
24
Medicare Patients
6,413
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$739.01 (53.3%)
Other$538.88 (38.9%)
Education$108.99 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $739.01 | 19 | 53.3% |
| Honoraria | $350.00 | 1 | 25.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $188.88 | 2 | 13.6% |
| Education | $108.99 | 2 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $464.29 | 4 | $0 (2019) |
| EPI Health, LLC | $215.72 | 3 | $0 (2022) |
| Dermavant Sciences, Inc. | $139.19 | 2 | $0 (2023) |
| GENZYME CORPORATION | $128.48 | 3 | $0 (2022) |
| PFIZER INC. | $116.39 | 2 | $0 (2017) |
| Journey Medical Corporation | $106.55 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $94.99 | 1 | $0 (2023) |
| Allergan, Inc. | $51.53 | 3 | $0 (2021) |
| Genentech USA, Inc. | $16.45 | 1 | $0 (2017) |
| Helsinn Therapeutics (U.S.), Inc. | $14.25 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $220.18 | 2 | Dermavant Sciences, Inc. ($125.19) |
| 2022 | $335.38 | 6 | EPI Health, LLC ($188.88) |
| 2021 | $146.78 | 4 | GENZYME CORPORATION ($115.89) |
| 2020 | $60.28 | 3 | EPI Health, LLC ($26.84) |
| 2019 | $451.37 | 3 | Biofrontera Inc. ($451.37) |
| 2018 | $12.92 | 1 | Biofrontera Inc. ($12.92) |
| 2017 | $159.97 | 5 | PFIZER INC. ($116.39) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.19 | General |
| Category: DERMATOLOGY | ||||||
| 04/17/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 12/09/2022 | EPI Health, LLC | WYNZORA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $96.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/23/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/17/2022 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $106.55 | General |
| 08/08/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Immunology | ||||||
| 05/24/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Immunology | ||||||
| 03/31/2022 | EPI Health, LLC | WYNZORA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $92.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/12/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/07/2021 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $101.15 | General |
| Category: Immunology | ||||||
| 03/04/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Dermatology | ||||||
| 02/25/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Immunology | ||||||
| 12/11/2020 | EPI Health, LLC | Sitavig (Drug), Cloderm, Minolira 105mg | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: Dermatology | ||||||
| 06/29/2020 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| 11/25/2019 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Dermatology | ||||||
| 11/04/2019 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Honoraria | Cash or cash equivalent | $350.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2019 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $87.04 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $12.92 | General |
| Category: Dermatology | ||||||
| 10/04/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2017 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: BioOncology | ||||||
| 04/18/2017 | Allergan Inc. | ACZONE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DERMATOLOGY | ||||||
| 04/12/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,659 | 4,646 | $428,272 | $271,781 |
| 2022 | 21 | 1,615 | 4,155 | $397,273 | $265,986 |
| 2021 | 18 | 1,676 | 4,013 | $412,692 | $289,382 |
| 2020 | 17 | 1,463 | 3,734 | $321,080 | $207,721 |
Total Patients
6,413
Total Services
16,548
Medicare Billing
$1.0M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 351 | 1,371 | $109,281 | $80,331 | 73.5% |
| 10040 | Acne surgery | Office | 2023 | 95 | 552 | $61,460 | $45,058 | 73.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 224 | 352 | $41,380 | $29,903 | 72.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 117 | 203 | $34,178 | $24,485 | 71.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 191 | 263 | $46,025 | $20,495 | 44.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 121 | 605 | $36,837 | $14,992 | 40.7% |
| 17340 | Cold treatment of acne | Office | 2023 | 95 | 551 | $31,023 | $12,264 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $12,155 | $8,579 | 70.6% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 28 | 118 | $8,953 | $6,507 | 72.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 92 | 132 | $13,100 | $5,704 | 43.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 21 | 48 | $6,281 | $4,880 | 77.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 82 | 92 | $6,820 | $4,270 | 62.6% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 18 | 21 | $4,750 | $3,382 | 71.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $5,634 | $3,353 | 59.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 31 | 36 | $4,631 | $3,296 | 71.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 19 | 24 | $2,950 | $2,136 | 72.4% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 12 | 104 | $2,425 | $1,866 | 77.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 47 | 59 | $390.68 | $278.44 | 71.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 790 | $92,101 | $66,784 | 72.5% |
| 10040 | Acne surgery | Office | 2022 | 97 | 504 | $55,736 | $41,884 | 75.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 619 | $48,845 | $37,995 | 77.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 84 | 155 | $26,106 | $18,779 | 71.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 149 | 209 | $28,663 | $17,398 | 60.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 131 | 146 | $22,929 | $14,821 | 64.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 123 | 550 | $33,476 | $14,217 | 42.5% |
About Dr. Diana Trusky, MD
Dr. Diana Trusky, MD is a Specialist healthcare provider based in Red Bank, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245238294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diana Trusky, MD has received a total of $1,387 in payments from pharmaceutical and medical device companies, with $220.18 received in 2023. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($739.01).
As a Medicare-enrolled provider, Trusky has provided services to 6,413 Medicare beneficiaries, totaling 16,548 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Red Bank, NJ
- Active Since 07/13/2005
- Last Updated 03/28/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245238294
Products in Payments
- AMELUZ (Drug) $437.04
- WYNZORA (Drug) $188.88
- VTAMA (Drug) $139.19
- DUPIXENT (Biological) $128.48
- EUCRISA (Drug) $116.39
- TREMFYA (Drug) $94.99
- Ameluz (Drug) $27.25
- Sitavig (Drug) $26.84
- BOTOX COSMETIC (Biological) $19.19
- BOTOX (Biological) $16.91
- Erivedge (Biological) $16.45
- ACZONE (Drug) $15.43
- VALCHLOR (Drug) $14.25
- Seysara (Drug) $13.98
- TALTZ (Drug) $13.36
- DORYX (Drug) $11.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Red Bank
Dr. Richard Haddad, Md, MD
Specialist — Payments: $1.5M
Specialist $1.5M
Dr. Edward Allegra, Md, MD
Specialist — Payments: $273,313
Specialist $273,313
Usha Niranjan, M.d, M.D
Specialist — Payments: $1,954
Specialist $1,954
Mr. Robert Gabel, Md, MD
Specialist — Payments: $414.30
Specialist $414.30
Dr. Thomas Theocharides, Md, MD
Specialist — Payments: $339.86
Specialist $339.86
Dr. Frederick Stone, M.d, M.D
Specialist
Specialist